Investment case
Boston Scientific Corporation
BSX · 2 developments mapped · last assessed 2026-09-01
Market Ontology has mapped 2 macro, policy, and market developments to Boston Scientific Corporation since 2026-08-26. Each one is traced from the driver to the valuation assumption it moves, and the valuation below is run on the same engine the subscription uses.
Valuation
No validated run has been published for BSX yet, so no modelled value is shown. The BSX valuation is in the public catch-up queue.
Subscribers do not wait for the weekly cycle: they run BSX on demand, against live prices and the latest filings, and change any assumption the developments below move.
Filed financials
Current case
- Main threat
Boston Scientific Corp Discloses Global Operational Disruption from Cybersecurity Incident
Direct operational disruption impacting sales and potentially incurring remediation costs.
· Moves near term revenue growth, operating efficiency, reputational risk premium
- Open question
Medtronic plc Completes Acquisitions of Scientia Vascular and SPR Therapeutics, Inc.
Increased competitive pressure in specific medical device segments where Medtronic's newly acquired assets operate. Potential for accelerated M&A activity among peers.
· Moves market share assumptions, competitive landscape
What changed, by assumption
- 2026-08-26Boston Scientific Corp Discloses Global Operational Disruption from Cybersecurity Incident
- 2026-09-01Medtronic plc Completes Acquisitions of Scientia Vascular and SPR Therapeutics, Inc.
Event impact log
Full ledger →| Date | Mechanism | Direction | Horizon | Impact |
|---|---|---|---|---|
| 2026-09-01 | Medtronic plc Completes Acquisitions of Scientia Vascular and SPR Therapeutics, Inc. | watch | 3-12m | 0.20 |
| 2026-08-26 | Boston Scientific Corp Discloses Global Operational Disruption from Cybersecurity Incident | Bearish | 1-3m | 0.90 |